Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda holds an exclusive agreement with the Weizmann Institute to commercialize the unique intellectual property developed by the scientists. The income generated serves to support further basic research and science education. - Identify and assess research projects with commercial potential. - Protect the intellectual property of the Institute and its scientists. - Create business relationships and license the Institute’s inventions and technologies to the industry. - Channel funding from industry to research projects. For further information please contact Tamir Huberman, CIO and Head of Marketing

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

Beijing Kelinen Biotechnology Co., Ltd., established on 2018-06-25, Business scope includes technical services,technology transfer,technology development,Technology Promotion,technical consulting;market survey;Business Management Consulting;Urban Landscaping Services;Economic and Trade Consulting;Sports project management(Except for high-risk sports);Technical testing;Sales of Class I Medical Devices,daily necessities,metallic material,Chemical Products(Free of Hazardous Chemicals),Equipment,Communication equipment,computer,Software and Auxiliary Equipment;Import and export;Technology Import and Export;Agent import and export.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.

Chiron Corporation (/ˈkaɪrɒn/ KY-ron) was an American multinational biotechnology firm based in Emeryville, California that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines, and blood testing. Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline.

Shenzhen Sail Cell Technology Co., Ltd., established on 2013-04-28, Business scope includes general business items:Research and development of biological and cell product technology;Research and development of biotherapeutic technology,technical consulting;Sales of cell culture-related reagents;Domestic Trade.,The licensing program is:

Jiangsu Huatai Vaccine Engineering Technology Research Co., Ltd., established on 2011-03-17, Business scope includes research and development of vaccine engineering technology,Biological product,drug development,technology transfer,technical consulting,Technical Services,Biological product,medicine,Food Inspection Services,File Management Service,Invest in the pharmaceutical industry with own funds,Realtor,property management,Water bill collection,electricity bill,Sales of daily necessities,Medical device production,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Beijing Jiadehe Cell Therapy Technology Co., Ltd., established on 2016-09-19, Business scope includes technology development,technical consulting,Technical Services,technology transfer;Technical testing;Medical Research and Experimental Development;health management,Health Advisory(Except for medical treatment activities subject to approval);Engineering and Technology Research and Experimental Development.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Immunomedics is a biopharmaceutical company that specializes in developing monoclonal antibody-based products for the treatment of cancer and other serious diseases. Its corporate objective is to become a fully-integrated biopharmaceutical company. The company was founded in 1982 and headquartered in Morris Plains, New Jersey.

Guangdong Age Value Biotechnology Co., Ltd., established on 2020-04-10, Business scope includes general items:R&D and application of cell technology;Development of Human Gene Diagnosis and Therapy Technology;Medical Research and Experimental Development;Human stem cell technology development and application;Natural science research and experimental development;Remote Health Management Services;Health Consulting Services(Does not include medical services);General merchandise sales;Cosmetics Wholesale;Information system integration service;Technology intermediary service;Sales of Class II Medical Devices;Cosmetics Retail;Healthy food(prepackaged)Sales;Information Technology Consulting Services;Technology Import and Export;Import and export;Information Consulting Service(Not including licensing information consulting services);Customs clearance;Inspection business;data processing services;Fermentation process optimization technology research and development;Quantum Computing Technology Services;Research and development of bio-based materials technology;Artificial intelligence application software development;Extraction of marine bioactive substances,purification,Synthesis technology research and development;Non-residential real estate leases;property management;Domestic trade agent;brand management;internet sales(Except for products that require a license for sale).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:food sales;medical service;Drug import and export;Drug retail;Bonded Warehouse Operation.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Mor Research Applications is the Technology Transfer Office of Clalit Health Services, the largest HMO in Israel, providing end-to-end technology transfer services. MOR helps inventors translate new ideas in the medical, pharmaceutical, diagnostics, medical IT, and biotechnology areas into products and solutions that benefit healthcare providers and patients.

Tianjin Kangting Bioengineering Group Co., Ltd., established on 1996-09-09, Business scope includes cosmetics,Production of hygiene products,manufacture,processing,Sales;Sell ​​dropshipping products in dropshipping style142kind(The product list is subject to the direct sales product list approved by the Ministry of Commerce);food production,Sales;Wujinjiaodian,Chemical Products(Hazardous chemicals and precursor chemicals are excluded),Daily necessities,building materials,Decoration materials,department store,household appliances,Health Products Sales;Hotel Management Services;General cargo transportation;Business Management Consulting Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Henan Rundun Biotechnology Co., Ltd., established on 2021-02-04, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Health Consulting Services(Does not include medical services);Sports Health Service;Information Technology Consulting Services;Software outsourcing service;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Cosmetics Wholesale;Cosmetics Retail;Daily necessities sales;software development(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Guangdong Kangdun High-tech Industry Group Co., Ltd., established on 2020-11-04, Business scope includes medical research and experimental development;Health Consulting Services(Does not include medical services);Engage in investment activities with own funds;Entrepreneurial Space Services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Park Management Services;Import and export;Technology Import and Export

Shanghai Puming Biotechnology Co., Ltd., established on 2017-05-02, Business scope includes biotechnology,Technology development in the field of medical science and technology,technical consulting,technology transfer,Technical Services,laboratory equipment,Chemical products and raw materials(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals)promotion of,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Beijing Xinshengyuan Biomedical Technology Co., Ltd., established on 2014-03-20, Business scope includes technology development,technology transfer,technical consulting,Technical Services,Technology Promotion;Sell ​​Home Appliances,computer,Software and Auxiliary Equipment,Instrumentation,medical instrumentsIkind;Natural science research and experimental development;Engineering and Technology Research and Experimental Development;Agricultural Science Research and Experimental Development;Medical Research and Experimental Development;data processing(Bank Card Center in Data Processing,PUEvalue in1.5Except for the above cloud computing data centers);repair computer;Basic software service;Application software service;software development;software consulting;Machinery and Equipment Leasing(Car rental not included);Investment Advisory;Educational Consulting(Except for intermediary services);Cultural Consulting;Conference Services;Undertake exhibition and display activities.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA.